Back

Reducing low density lipoprotein cholesterol (LDL-C) in homozygous familial hypercholesterolemia (HoFH) with a microsomal triglyceride transfer protein (MTP) inhibitor may reduce CV events

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: What's new in hereditary dyslipidaemia? Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Helen Phillips

Shrewsbury (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Antioxidant property of high-density lipoprotein predicts the presence of atherosclerotic cardiovascular disease and corneal arcus in patients with familial hypercholesterolemia
Doctor M. Ogura (Urayasu, JP)
Abstract Slides Video
Presentation thumbnail
Lp(a) levels predict cardiovascular events in patients with Familial Hypercholesterolemia but not in unaffected relatives. SAFEHEART registry results.
Doctor L. Perez De Isla (Madrid, ES)
Abstract Slides
Presentation thumbnail
Familial hypercholesterolaemia diagnosis: a case of missed opportunity
Professor K. Ray (London, GB)
Abstract Slides Video
Presentation thumbnail
Whole exome sequencing in primary severe hypertriglyceridemia
Doctor H. Tada (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Prevalence, clinical features, and prognosis of patients with extremely low high-density lipoprotein cholesterol
Doctor H. Tada (Kanazawa, JP)
Abstract Slides Video

Access the full session

Session thumbnail
What's new in hereditary dyslipidaemia?

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources